Dana Farber Harvard Cancer Center Consortium

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

NSCLC

Studies at this site

• A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer — Recruiting now